HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Fluconazole in the treatment of dermatomycoses. Clinical experience].

Abstract
Twenty patients suffering from dermatomycosis have been treated with fluconazole at the dose of 50 mg/daily for 20 days. These patients (10 M + 10 F) were aged 36 years on average (range 17-65 years). And were suffering from the following: Tinea pedis (3 cases), Tinea cruris (1 case), Tinea corporis (9 cases), Tinea versicolor (3 cases), Candidiasis (5 cases). One patient was suffering from Tinea on two different body sites. 19 patients finished the treatment and reported a complete clinical and mycological healing either at the end of the therapy on at follow-up visits. One patient, who was already suffering from gastritis, had to interrupt the therapy early due to abdominal pain. General safety was excellent.
AuthorsA Zucchi, G De Panfilis, F Allegra
JournalGiornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia (G Ital Dermatol Venereol) Vol. 125 Issue 1-2 Pg. I-III (Feb 1990) ISSN: 0392-0488 [Print] Italy
Vernacular TitleIl fluconazolo nel trattamento delle epidermomicosi. Esperienze cliniche.
PMID2365398 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Fluconazole
Topics
  • Adolescent
  • Adult
  • Aged
  • Dermatomycoses (drug therapy)
  • Drug Evaluation
  • Female
  • Fluconazole (therapeutic use)
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: